View Post

Most Oncology Trials Fail to Report Timely Results

In Clinical Studies News by Barbara Jacoby

By: Mike Bassett From: medpagetoday.com Situation steadily improving since passage of FDAAA, however While fewer than 40% of completed oncology trials in 2017 reported their results in a timely fashion, that percentage was eight times higher compared with a decade ago, researchers reported. Among more than 12,000 clinical trials registered in ClinicalTrials.gov, the percentage reporting results within 24 months of …

View Post

Breast Cancer and Shingles

In In The News by Barbara Jacoby

Source: FeatureFriday From: survivingbreastcancer.org Is there a relationship? Studies indicate that there may be a correlation. Talk about one’s body multi-tasking in a most adversarial way! During a recent survivingbreastcancer.org virtual meet up, a number of the community stated they had developed shingles. The conversation stimulated much in the way of follow up. What we do know: Shingles is caused …

View Post

New biosensor developed to aid early diagnosis of breast cancer

In Clinical Studies News by Barbara Jacoby

By: Universitat Politècnica de València From: medicalxpress.com A team of Spanish researchers have developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. One of the team coordinators has been Ramón Martínez Máñez, a professor at the Universitat Politècnica de València (UPV) and the scientific director of the Networking Biomedical …

View Post

Radical Mastectomy: What You Need to Know

In In The News by Barbara Jacoby

From: healthline.com A mastectomy is surgery to remove a breast. There are several types of mastectomy, including total, modified radical, and radical. A radical mastectomy is the most extensive type. During the procedure, the surgeon removes the entire breast along with the underarm (axillary) lymph nodes and chest wall muscles. In this article, we’ll take a closer look at radical …

View Post

Tumor marker may help overcome endocrine treatment-resistant breast cancer

In Clinical Studies News by Barbara Jacoby

By: Sanford Burnham Prebys Medical Discovery Institute From: medicalxpress.com A study led by scientists at Sanford Burnham Prebys Medical Discovery Institute has identified a tumor marker that may be used to predict which breast cancer patients will experience resistance to endocrine therapy. The research offers a new approach to selecting patients for therapy that targets HER2, a protein that promotes …

View Post

What Mammogram Alternatives Are Available and Do They Work?

In In The News by Barbara Jacoby

From: healthline.com Alternatives to mammograms Mammography uses radiation to produce detailed images of the breasts. It’s used in routine screening and to aid in the diagnosis of breast cancer. In the United States, mammograms are a common early detection tool. In 2013, 66.8 percentTrusted Source of women 40 years old and over had had a mammogram within the previous two …

View Post

Rare Patient Voice: Paid Opportunity for Follicular Lymphoma & Mantle Cell Lymphoma Patients in the US

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min interview + 10 min pre-task Compensation $120 * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why Sign up with …

View Post

Alpelisib Plus Fulvestrant Shows Activity Following CDK4/6 Inhibition for HR+/HER– Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Matthew Fowler From: cancernetwork.com The combination of alpelisib and fulvestrant maintained a tolerable safety profile for patients with PIK3CA-mutated, hormone receptor–positive, HER2-negative advanced breast cancer who progressed after previous treatment with a CDK4/6 inhibitor. Alpelisib (Piqray) plus fulvestrant (Faslodex) produced activity while maintaining a tolerable safety profile for patients with PIK3CA-mutated, hormone receptor­–positive, HER2-negative advanced breast cancer who progressed …

View Post

Susan G. Komen and Amgen to Help People Understand and Monitor Breast and Bone Health

In In The News by Barbara Jacoby

From: businesswire.com Bone Complication Impacts 70% of People Living with Metastatic Breast Cancer Susan G. Komen®, the world’s leading breast cancer organization, today unveiled a new integrated campaign, in partnership with Amgen, to educate the breast cancer community about the link between breast and bone health, providing useful information for women of all ages and stages of breast cancer. “Breast …